This paper describes research into the anticipated processes and data needed to inform decision-making on malaria vaccines, the most advanced of which is still in phase 3 trials.
Author(s): Brooks A, Ba-Nguz A
Corporate author(s): PATH, Swiss Tropical and Public Health Institute
Publication date: February 2012
2,830 KB PDF
Hard copies are not available.
Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.
Related regions: Africa
For more information…
Contact: PATH Publications
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA